Birchtech Corp. (AMEX: BCHT) has completed its uplisting to the NYSE American exchange following a reverse stock split and public offering, marking a significant milestone for the cleantech company specializing in sustainable air and water treatment solutions. The company's transition from over-the-counter trading comes alongside substantial financial developments that could reshape its market position.
The public offering involved approximately 6.25 million shares of common stock at an assumed price of $2.40 per share, generating about $15 million based on the last reported sale price from January 9, 2026. This capital raise follows a strategic 1-for-5 reverse stock split approved in late December, which company leadership described as essential for improving the stock price and supporting the uplisting process. Richard MacPherson, President & CEO of Birchtech Corp., stated that the reverse split was expected to "elevate the company's capital market profile" and provide access to institutional capital that could enhance liquidity and broaden market reach.
Birchtech's financial position has been further strengthened by a recent legal victory in a patent lawsuit dating back to July 2019. While initially awarded $57 million, the company now expects the final judgment to reach $78 million. This settlement, combined with the $20 million from the public offering, provides substantial resources for business expansion. The company plans to use these funds to increase market share across the U.S. coal-fired power fleet and fund expansion in the water purification market. Birchtech anticipates gaining numerous new licenses and supply contracts with utilities using its patented technologies for mercury emissions capture, with typical agreements extending between 3-5 years.
The company's water treatment business has gained momentum after three years of development, with purchase orders totaling $0.9 million from a mid-Atlantic power utility. Birchtech has also established a partnership with Civil & Environmental Consultants Inc. (CEC) to provide testing services to utility customers and reports a robust pipeline of potential water treatment projects. This expansion comes amid growing concerns about water contamination, particularly regarding persistent pollutants like PFAS "forever chemicals" linked to serious health risks including low birth rates, increased cancer risks, and high blood pressure in pregnant women.
Birchtech's dual focus on air and water purification addresses critical environmental challenges while positioning the company for growth in markets demanding more effective and affordable contamination solutions. The combination of legal settlement funds, public offering capital, and NYSE American listing creates a foundation for expanded operations and increased investor attention in 2026. Additional information about the company's developments can be found at https://www.newmediawire.com, while market context is available through https://www.benzinga.com.
